Annual revenue of INKON Life Technology 2015-2023
In 2023, INKON Life Technology generated a revenue of 1.47 billion yuan. Formerly known as Starmap Medicine, the company is a subsidiary of Haier Group and focuses on high-tech oncology equipment and cancer treatment. INKON Life Technology was incubated by Haier which currently holds a controlling stake of 40 percent of shares.